ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP05

Race for Relapsing Polychondritis Drives Awareness, Accelerates Research, and Improves the Quality of My Life: How Motorsports Help Me Overcome the Hopelessness of an Incurable, Rare Disease

Nancy Linn1, 1RPASF Inc.

Meeting: 2019 ACR/ARP Annual Meeting

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Patient Perspectives Poster Session

Session Type: Poster Session (Sunday)

Session Time: 11:30AM-1:30PM

Background/Purpose: Like many other patients with a rare disease, I felt relieved when I finally received a diagnosis: relapsing polychondritis or “RP”.  However, once I started researching the disease, the scant information available wasn’t encouraging. Most sources described RP as fatal – a shock to read at 54 years of age. Through a Facebook group for RP patients, I was introduced to physicians, specialists, and researchers, all of whom became essential for our future collaborations benefiting RP patients. However, I soon realized that my communications with doctors and other patients all revolved around RP, and I wanted a forum where we could engage outside the hopelessness of an incurable illness.

Treatment: In 2016, I founded Race for RP, an organization that partners with motorsports drivers and teams to support research, awareness, and quality care for RP patients. Since then, we’ve seen our logo zip across the finish line first, but the real victories have been solidifying the ties between care providers. For example, at one race, we invited the leader of an autoimmunity institute to have the organization’s logo on a professional sports car. He accepted, and that car won the race, garnering international publicity and paving the way for future partnerships. At the same time, engaging with my community outside of hospitals and the Facebook group provides support centered on positive actions, like riding my bike for our cycling fundraisers.

Maintenance: In between getting news of more cartilage damaged, Race for RP gives me purpose and hope. Over Memorial Day Weekend, I was on my way to a friend’s wedding instead of watching one of our professional drivers compete in a world-renowned automobile race – with our logo on the car! As I traveled to the wedding, I watched footage of the race on my phone.  After losing cell service, I listened on satellite radio. Thankfully, the last lap was finished before the wedding reception, or I may have had to sneak into the bathroom to hear who won. The awareness generated by Race for RP’s drivers and teams has been wonderfully distracting from the symptoms of the disease and sparked many positive, fun conversations with other autoimmune disease patients and motorsports enthusiasts.  Race for RP has also improved my physical health through its collaboration with other organizations, which has provided me (and other patients) with access to specialists I never could’ve found on my own.

Quality of Life: Race for RP has greatly improved my quality of life, and one of my proudest moments was after last year’s ACR/ARP Annual Meeting.  There, Race for RP provided funding for 2 Exhibitor booths and hosted 2 affiliated educational events with highly regarded rheumatologists and epidemiologists. These awareness-generating events helped make RP the most searched disease (on a top search engine) in the host state. I feel this same pride when I see the Race for RP logo on race cars, mobile phones, windows of businesses in town, hats of a stranger, or the wristbands of my global friends.  Race for RP is good for my health – mental and physical.

Illustration of the Race for RP No. 153 Ferrari Challenge Car

After a Long Day of Riding on a Michigan Cycling Tour in Support of Race for RP

The Race for Relapsing Polychondritis Logo with Website Information


Disclosure: N. Linn, None.

To cite this abstract in AMA style:

Linn N. Race for Relapsing Polychondritis Drives Awareness, Accelerates Research, and Improves the Quality of My Life: How Motorsports Help Me Overcome the Hopelessness of an Incurable, Rare Disease [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/race-for-relapsing-polychondritis-drives-awareness-accelerates-research-and-improves-the-quality-of-my-life-how-motorsports-help-me-overcome-the-hopelessness-of-an-incurable-rare-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/race-for-relapsing-polychondritis-drives-awareness-accelerates-research-and-improves-the-quality-of-my-life-how-motorsports-help-me-overcome-the-hopelessness-of-an-incurable-rare-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology